In addition, our own studies have identified hypoxic tumor markers, such as osteopontin (OPN), vascular endothelial growth factor (VEGF) and carbonic anhydrase IX (CAIX) as prognostic factors in NSCLC with radiation therapy (RT) [14,15]. The gene discussed is CA9; the disease is non-small cell lung carcinoma.